Developing Innovative Treatments for Various Forms of Life-Threatening Fibrotic Disease.

Therapeutic Focus

Mini Stroke

Neurodegenerative Disease

A radiation therapy machine is located in a state-of-the-art medical facility, ready for use in cancer treatment.

Molecular Imaging & Radiotherapy

Human liver with hepatitis virus. 3d illustration

Fibrotic Disease

Close up of doctor typing and looking at laptop with DNA hologram. Remedial.

Diagnostics & CNS Big Data

Pioneering Therapeutics for Fibrosis

Theraly Fibrosis is a preclinical-stage company whose mission is to develop innovative treatments for various forms of fibrotic disease including chronic pancreatitis, systemic sclerosis, and NASH. The company’s lead candidate, TLY012, selectively targets myofibroblasts, cells believed to be the critical originators of fibrosis, a condition that affects a variety of tissues.

Biotechnology

Contact Us

Want to learn more about Theraly Fibrosis or have a question about our approach? Use the contact form and let’s start a conversation.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.